Medical Affairs Specialist Elanco Animal Health University Place, Washington, United States
Disclosure(s):
Chris George, DVM: No relevant disclosure to display
This presentation will discuss two common conditions associated with CKD, anemia and weight loss. Primary focus will be on recognizing nonregenerative anemia and the mechanisms that cause this condition, as well as therapeutic options. Special focus will be on molidustat, the first ever HIF-PH inhibitor in veterinary medicine, as a first-in-class option for the treatment of nonregenerative anemia of CKD in cats.
Learning Objectives:
Realize the impact of anemia on cats with CKD
Understand the HIF-PH pathway and its role in erythropoietin production.
Understand proper use and monitoring of cats being treated with molidustat (Varenzin-CA1).
Appreciate the role of maintaining weight with capromorelin (Elura) in cats with CKD
.png)
